Elekta Financial Statements From 2010 to 2025

EKTAY Stock  USD 6.09  0.05  0.81%   
Elekta AB's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Elekta AB's valuation are provided below:
Elekta AB ADR does not presently have any fundamental signals for analysis.
Check Elekta AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elekta AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Elekta financial statements analysis is a perfect complement when working with Elekta AB Valuation or Volatility modules.
  
This module can also supplement various Elekta AB Technical models . Check out the analysis of Elekta AB Correlation against competitors.

Elekta AB ADR Company Current Valuation Analysis

Elekta AB's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Elekta AB Current Valuation

    
  2.81 B  
Most of Elekta AB's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elekta AB ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Elekta AB ADR has a Current Valuation of 2.81 B. This is 80.42% lower than that of the Healthcare sector and 69.24% lower than that of the Medical Instruments & Supplies industry. The current valuation for all United States stocks is 83.08% higher than that of the company.

Elekta AB ADR Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Elekta AB's current stock value. Our valuation model uses many indicators to compare Elekta AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elekta AB competition to find correlations between indicators driving Elekta AB's intrinsic value. More Info.
Elekta AB ADR is rated # 3 in return on equity category among its peers. It is rated # 4 in return on asset category among its peers reporting about  0.36  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Elekta AB ADR is roughly  2.80 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Elekta AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Elekta AB's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Elekta AB Financial Statements

Elekta AB investors use historical fundamental indicators, such as Elekta AB's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elekta AB. Please read more on our technical analysis and fundamental analysis pages.
Elekta AB , a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden. Elekta B operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 4700 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Elekta Pink Sheet Analysis

When running Elekta AB's price analysis, check to measure Elekta AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elekta AB is operating at the current time. Most of Elekta AB's value examination focuses on studying past and present price action to predict the probability of Elekta AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elekta AB's price. Additionally, you may evaluate how the addition of Elekta AB to your portfolios can decrease your overall portfolio volatility.